| Literature DB >> 32351487 |
Eleni Bratanis1, Tilde Andersson1, Rolf Lood1, Ewa Bukowska-Faniband1.
Abstract
Bdellovibrio and like organisms (BALOs) are obligate predatory bacteria that selectively prey on a broad range of Gram-negative bacteria, including multidrug-resistant human pathogens. Due to their unique lifestyle, they have been long recognized as a potential therapeutic and biocontrol agent. Research on BALOs has rapidly grown over the recent decade, resulting in many publications concerning molecular details of bacterial predation as well as applications thereof in medicine and biotechnology. This review summarizes the current knowledge on biotechnological potential of obligate predatory bacteria and their secreted enzymes.Entities:
Keywords: antibiotic resistance; antibody modification; biocontrol; biofilm; biotechnology; predatory bacteria
Year: 2020 PMID: 32351487 PMCID: PMC7174725 DOI: 10.3389/fmicb.2020.00662
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Schematic representation of B. bacteriovorus life cycle (for a detailed description see text). AP, attack phase; GP, growth phase.
FIGURE 2An overview on the mechanisms of spread of ARGs in mixed microbial communities (e.g., in WWTPs) and suggested role of predatory bacteria in limiting thereof. (A) Microbial communities that consist of both susceptible and resistant bacteria are exposed to a variety of stressors (e.g., antibiotics) in the environment, leading to selective pressure and expansion of resistant populations (B1). BALOs may predate on such resistant population to reduce the ARGs pool. Antibiotics can also trigger induction of prophages that are capable of transduction as well as the release of resistance genes (B2). Through host competition, i.e., BALOs preying on bacterial cells also targeted by phages for propagation, the number of phages carrying resistance genes will be limited. The expanding population of resistant bacteria (B1), as well as the mobilized resistome (B2) are capable of spreading resistance via conjugation, transformation and transduction events (C). Besides the ability of BALOs to limit spread of resistance through predation of bacterial cells (limit conjugation), its plethora of hydrolytic enzymes can lead to nucleolytic degradation of cell-free DNA (limit transformation) and inactivation of phage particles through action of secreted proteases (limit transduction); thus dictating the outcome of spread.
FIGURE 3Overview of BALOs biotechnological applications discussed throughout the review.